As we draw curtains on 2015, it is almost the dawn of worrying times for the Indian Pharmaceutical sector. It is raining warning letters for many India-based pharma companies. The latest to be hit is one of the most major pharma players in the country, Cadila Healthcare. The company saw a double digit slump in the stock market after the US Food and Drug Administration received warning letters for two […]